You are here

A Global Active Surveillance for Community Acquired Pneumonia

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Chrzanow, , 32-500 Poland
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Community Acquired Pneumonia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adult subjects 50 years of age or older

- Subject must reside in the surveillance area

- Subjects who present to a study healthcare facility where the treating physician
clinically suspects CAP

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any subject who is transferred to a study healthcare facility after already being
hospitalized for 48 hours or more at any other in-patient facility (such as a
community hospital).

- Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being
hospitalized for 48 hours or more).

NCT00929721
Pfizer
Completed
A Global Active Surveillance for Community Acquired Pneumonia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now